Diastereomers of the Anticancer Peptide CIGB-300 with Altered β-Turn Structures
Sign Up to like & getrecommendations! Published in 2024 at "International Journal of Peptide Research and Therapeutics"
DOI: 10.1007/s10989-024-10662-2
Abstract: The next-generation anti-tumor drug peptide CIGB-300, developed by the Center for Genetic Engineering and Biotechnology (CIGB), targets casein kinase 2 (CK2) and its substrates, implicating significant therapeutic potential in cancer treatment. A key focus of… read more here.
Keywords: turn; cigb 300; cigb; cigb 300iso ... See more keywords